[Therapeutic effect of clioquinol for Alzheimer disease].
Iwata
Noriyoshi
N
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000209:etiology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D018685:Anesthetics, Inhalation / Q000037:antagonists & inhibitors; D000818:Animals; D001921:Brain / Q000378:metabolism; D053148:Caspase 3 / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D017322:Clinical Trials, Phase II as Topic; D007464:Clioquinol / Q000494:pharmacology / Q000627:therapeutic use*; D003300:Copper / Q000378:metabolism; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007477:Ions; D007530:Isoflurane / Q000037:antagonists & inhibitors; D051379:Mice; D015032:Zinc / Q000378:metabolism
D016229:Amyloid beta-Peptides; D018685:Anesthetics, Inhalation; D007477:Ions; D003300:Copper; D007464:Clioquinol; D002784:Cholesterol; D007530:Isoflurane; D053148:Caspase 3; D015032:Zinc